← Search

Data · dataset · 2026

Survival Status of MST and Control Groups at Wuhan Central Hospital - Data Statistics

Listed in ScienceDB

Description

This was a single-center retrospective study including patients diagnosed and treated for Acute Myeloid Leukemia (AML) at the Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology between January 2021 and July 2025. A total of 55 patients were enrolled: 20 received venetoclax combined with azacitidine followed by microtransplantation (MST group), 35 received venetoclax combined with azacitidine alone (Control group).Include Prognostic stratification,fit/unfit,State of survival,OS and DFS.

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Oncology and carcinogenesis 68%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
ScienceDB10.57760/sciencedb.4539012 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:group:3211enrichment · scidb cntaxonomy-embedding@1.0.0title+keywords+description (68%)
concepts[field].local:field:earth-environmentalmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:engineeringmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:humanitiesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:life-sciencesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:medicine-healthmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:social-sciencemapping · scidb cnconnector:scidb_cn@1.0.0
descriptionsource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/description
license_textsource · scidb cnconnector:scidb_cn@1.0.0
publication_datesource · scidb cnconnector:scidb_cn@1.0.0
titlesource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/title